PRODUCT USE IN UNAPPROVED INDICATION

This adverse event was reported 175151 times

These drugs are most commonly taken by patients reporting PRODUCT USE IN UNAPPROVED INDICATION:

# Drug Count
0 DUPILUMAB 18975
1 PREDNISONE 9536
2 DICLOFENAC SODIUM 8388
3 METHOTREXATE SODIUM 7636
4 METHOTREXATE 7071
5 ACETAMINOPHEN 6508
6 GABAPENTIN 6179
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 5793
8 MYCOPHENOLATE MOFETIL 5787
9 RISPERIDONE 5643
See all common drugs associated with PRODUCT USE IN UNAPPROVED INDICATION

PRODUCT USE IN UNAPPROVED INDICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBUPROFEN, ACETAMINOPHEN 1146 0.5929
1 METHOXSALEN 291 0.4583
2 IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE 286 0.2909
3 CAPLACIZUMAB 234 0.2147
4 CAFFEINE CITRATE 283 0.2114
5 PSEUDOEPHEDRINE HYDROCHLORIDE 761 0.1320
6 DICLOFENAC POTASSIUM TABLETS 481 0.1302
7 DICLOFENAC POTASSIUM 671 0.1132
8 PSEUDOEPHEDRINE HCL 759 0.1127
9 CORTISONE ACETATE 850 0.1063
See all drugs enriched for association with PRODUCT USE IN UNAPPROVED INDICATION

PRODUCT USE IN UNAPPROVED INDICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoactivated Radical Generator [EPC] 291 0.4583
1 Interleukin-4 Receptor alpha Antagonist [EPC] 18975 0.0908
2 Polyene Antimicrobial [EPC] 23 0.0819
3 Oxaborole Antifungal [EPC] 2 0.0714
4 Antiparasitic [EPC] 333 0.0681
5 Melanin Synthesis Inhibitor [EPC] 64 0.0677
6 Pediculicide [EPC] 333 0.0663
7 RNA Synthetase Inhibitor Antibacterial [EPC] 572 0.0569
8 Actinomycin [EPC] 133 0.0544
9 Anthelmintic [EPC] 130 0.0535
See all drug classes enriched for association with PRODUCT USE IN UNAPPROVED INDICATION